Cardiohepatic Syndrome: Innovative Diagnostics by Ultrasound Elastography

DOI: 10.47026/2413-4864-2022-1-9-18

UDC: [616.12-008.46-039+616.36]-073.43
BBC: Р410.09-439 + Р413.51-439

Vasilyeva L.N., Ksenofontova A.G., Bayukova S.V.

Cardiohepatic Syndrome: Innovative Diagnostics by Ultrasound Elastography

Keywords: chronic heart failure, liver, cardiohepatic syndrome, ultrasound diagnostics, liver elastography

The purpose of this work is to study the aspects of cardiohepatic syndrome at the present stage of medicine development, as well as the diagnostic opportunities of ultrasound elastography in its assessment. The methods of statistical analysis, generalization, comparison and systematization of data were used. The article describes in detail the current state of cardiohepatic syndrome problem. To date, the cardiohepatic syndrome, along with the well-studied cardiorenal one, is becoming more and more relevant, as it reflects the hepatotrophic effect of pathogenetic chronic heart failure factors on the liver tissue. The cardiohepatic syndrome in a broad sense is the presence of simultaneous liver and heart dysfunctions in the development of various nosologies. However, most often this symptom complex is described in the literature in a narrower sense – as a consequence of organ damage to the liver due to the development of acute and chronic heart failure. The main pathogenetic mechanism of cardiac hepatopathies is liver fibrosis. The prognosis of the disease and the life of patients depends on liver fibrosis advance. And early diagnosis of pre-existing fibrosis will make it possible to suspend the process of fibrotic scarring that has begun and its further transformation into cardiac liver cirrhosis. To date, the "gold standard" of fibrosis instrumental diagnosis is a liver biopsy, but due to restrictions and contraindications, the method is limited in its use. Ultrasound elastography is the main non-invasive method for diagnosing fibrosis. At the present stage of expanded diagnostic opportunities, several methods of ultrasonic elastography are described: strain elastography, point shear wave elastography (ARFI-elastometry), indirect transient elastography, two-dimensional shear wave elastography. The experience of using ultrasound elastography is described in the diagnosis of diffuse liver diseases – hepatitises, non-alcoholic fatty liver disease. As part of the cardiohepatic syndrome studying, the technique is innovative and requires further study.

References

Arisheva O.S., Garmash I.V., Sarlykov B.K. Rasprostranennost i prognosticheskoe znachenie porazheniya pecheni pri khronicheskoi serdechnoi nedostatochnosti [Prevalence and prognostic value of liver damage in chronic heart failure]. Klinicheskaya farmakologiya i terapiya, 2021, no. 30(1), pp. 70–74.
Balashova A.A., O.S. Arisheva O.S., Garmash I.V., Terebilina N.N., Baronets V.Yu., Kobalava Zh.D., Moiseev V.S. Fibroz pecheni: metody diagnostiki i vozmozhnosti otsenki pri serdechnoi nedostatochnosti [Liver fibrosis: diagnostic methods and assessment options in heart failure]. Klinicheskaya farmakologiya i terapiya, 2017, no. 26(3), pp. 1–6.
Balukova E.V., Uspenskii Yu.P., Fominykh Yu.A. Porazheniya pecheni razlichnogo geneza (toksicheskogo, lekarstvennogo, dismetabolicheskogo: ot etiologicheskoi geterogennosti k edinoi unifitsirovannoi terapii patsientov [Liver lesions of various origins (toxic, drug, dysmetabolic: from etiological heterogeneity to a single unified therapy for patients]. Russkii meditsinskii zhurnal Meditsinskoe obozrenie, 2018, vol. 2, pp. 35–40.
Diomidova V.N., Agafonkina T.V., Valeeva O.V., Spiridonova T.K. Ultrazvukovaya diagnostika organov bryushnoi polosti [Ultrasound diagnostics of the abdominal organs]. Cheboksary, 2015, 103 p.
Diomidova V.N., Vasilyeva L.N., Valeeva O.V., Petrova O.V. Vozmozhnosti ultrazvukovoi elastografii v otsenke porazheniya pecheni pri khronicheskoi serdechnoi nedostatochnosti [Possibilities of ultrasound elastography in assessing liver damage in chronic heart failure]. Prakticheskaya meditsina, 2021, no. 19, no. 5, pp. 27–32.
Kamalov Yu.R., Khutornoi I.V., Kryzhanovskaya E.Yu., Filin A.V., Morozova M.M. Tochechnaya elastografiya sdvigovoi volnoi (ARFI-elastometriya) pri khronicheskikh diffuznykh zabolevaniyakh pecheni nevirusnoi etiologii [Point shear wave elastography (ARFI-elastometry) in chronic diffuse liver diseases of non-viral etiology]. Ultrazvukovaya i funktsionalnaya diagnostika, 2018, no. 4, pp. 33–45.
Kobalava Zh.D., Villevalde S.V., Solov’eva A.E. Serdechno-pechenochnyi sindrom pri serdechnoi nedostatochnosti: rasprostranennost, patogenez, prognosticheskoe znachenie [Cardiohepatic syndrome in heart failure: prevalence, pathogenesis, prognostic value]. Kardiologiya, 2016, no. 12, pp. 1–9.
Mitkov V.V., Mitkova M.D. Ultrazvukovaya elastografiya sdvigovoi volnoi [Ultrasonic shear wave elastography]. Ultrazvukovaya i funktsionalnaya diagnostika, 2015, no. 2, pp. 94–108.
Morozov S.V., Trufanova Yu.M., Pavlova T.V., Isakov V.A., Kaganov B.S. Primenenie elastografii dlya opredeleniya vyrazhennosti fibroza pecheni: rezultaty registratsionnogo issledovaniya v Rossii [The use of elastography to determine the severity of liver fibrosis: results of a registration study in Russia]. Eksperimentalnaya i klinicheskaya gastroenterologiya, 2008, vol. 2, pp. 40–48.
Munkhtsetseg B. Kliniko-prognosticheskoe znachenie nepryamoi elastometrii pecheni pri dekompensatsii serdechnoi nedostatochnosti [Clinical and prognostic value of indirect liver elastometry in decompensated heart failure]. Moscow, 2019.
Pavlov Ch.S. Fibroz pecheni pri khronicheskikh virusnykh gepatitakh [Liver fibrosis in chronic viral hepatitis]. Moscow, 2009. 34 p.
Postnova N.A., Borsukov A.V., Morozova T.G., Ilyasov B.B., Andreev B.V. Ispolzovanie kompressionnoi elastografii dlya neinvazivnoi otsenki fibroza pecheni: rezultaty mnogotsentrovogo issledovaniya [Use of compression elastography for non-invasive assessment of liver fibrosis: results of a multicenter study]. Ultrazvukovaya i funktsionalnaya diagnostika, 2016, no. 6, pp. 10–21.
Soloveva A.E., Kobalava Zh.D., Villevalde S.V, Bayarsaikhan M., Garmash I.V., Fudim M. Prognosticheskoe znachenie plotnosti pecheni pri dekompensatsii serdechnoi nedostatochnosti: rezultaty prospektivnogo nablyudatel’nogo issledovaniya, osnovannye na dannykh ne-pryamoi elastometrii [Prognostic value of liver density in decompensated heart failure: results of a prospective observational study based on data from indirect elastometry]. Kardiologiya, 2018, vol. 28, no. 10S, pp. 20–32.
Storozhakov G.I., Gendlin G.E., Reznik E.V. Boleet serdtse – stradayut pochki: kardiorenalnyi sindrom pri khronicheskoi serdechnoi nedostatochnosti [The heart is sick – the kidneys suffer: cardiorenal syndrome in chronic heart failure]. Lechebnoe delo, 2009, no. 1, рр. 27–36.
Storozhakov G.I., Oskanova R.S., Ilchenko L.Yu. Gipoksicheskii gepatit [Hypoxic hepatitis]. Arkhiv vnutrennei meditsiny, 2014, vol. 6(20), рр. 42−47.
Tkach S.M. Zabolevaniya pecheni i pechenochnaya disfunktsiya u bolnykh s serdechnoi nedostatochnostyu [Liver disease and hepatic dysfunction in patients with heart failure]. Sertseva nedostatnіstta komorbіdnі stani, 2017, no. 3, рр. 90–96.
Allen L.A., Felker G.M., Pocock S. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur J Heart Fail., 2009, vol. 11, pp. 170–177.
Ambrosy A.P., Vaduganathan M., Huffman M.D. EVEREST Trial Investigators. Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial. Eur J Heart Fail., 2012, vol. 14(3), pp. 302–311.
Bagshaw S.M., Cruz D.N. Epidemiology of cardiorenal syndromes. Contrib Nephrol., 2010, vol. 165, pp. 68–82.
Dalos D., Binder C., Duca F. Serum levels of gamma-glutamyltransferase predict outcome in heart failure with preserved ejection fraction. Sci Rep, 2019, vol. 9, 18541.
Felder L., Mund A., Parker Jg. Liver function tests in chronic congestive heart failure. Circulation, 1950, vol. 2(2), pp. 286−297.
Fuhrmann V., Jager B., Zubkova A., Drolz A. Hypoxic hepatitis – epidemiology, pathophysiology, and clinical management. Wien Klin. Wochenschr., 2010, vol. 122 (5-6), pp. 129–139.
Ganne-Carrie N, Ziol M, de Ledinghen V. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology, 2006, vol. 44, pp. 1511–1517.
Garcia-Donaire J.A., Ruilope L.M. Cardiovascular and Renal Links along the Cardiorenal Continuum. Nephrology, 2013, vol.17(1), 11–19.
Giallourakis C.C. Liver complications in patients with congestive heart failure. Gastroenterol Hepatol (NY), 2013, vol. 9, pp. 244–246.
Nikolaou M., Parissis J., Yilmaz M. Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure. Eur Heart J, 2012, vol. 34(10), pp. 742–749.
Poelzl G., Auer J. Cardiohepatic syndrome. Curr Heart Fail Rep., 2015, no. 12(1), pp. 68−78.
Poelzl G., Ess M., Mussner-Seeber C. Liver dysfunction in chronic heart failure: prevalence, characteristics and prognostic significance. Eur J Clin Invest, 2012, vol. 42(2), pp. 153–163.
Saito Y, Kato M, Nagashima K. Prognostic relevance of liver stiffness assessed by transient elastography in patients with acute decompensated heart failure. Circ J, 2018, vol. 82(7), pp. 1822–1829.
Samsky M.D., Dunning A., DeVore A.D. Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF. Eur J Heart Fail, 2015, vol. 28.
Scholfield M., Schabath M.B., Guglin M. Longitudinal Trends, Hemodynamic Profiles, and Prognostic Value of Abnormal Liver Function Tests in Patients with Acute Decompensated Heart Failure: an Analysis of the ESCAPE Trial. J Card Fail, 2014, vol. 20(7), pp. 476–484.
Shah S.C., Sass D.A. A review of liver dysfunction in heart failure. Liver Res Open J. Cardiac Hepatopathy. 2015, vol. 1(1), pp. 1–10.
Taniguchi T., Sakata Y., Ohtani T., Mizote I., Takeda Y., Asano Y. Usefulness of Transient Elastography for Noninvasive and Reliable Estimation of Right-Sided Filling Pressure in Heart Failure. The American Journal of Cardiology, 2014, vol. 113, pр. 552–558.
Wong F., Greenbloom S., Blendis L. The liver in heart failure. In: Friedman L., Keeffe E. Handbook of Liver Disease. 2^nd ed. Churchill Livingstone. 2004.

About authors

Vasilyeva Lidiya N.: Senior Lecturer, Department of Propaedeutics of Internal Diseases with a Course of Radiation Diagnostics, Chuvash State University, Russia, Cheboksary (klni21@mail.ru; ORCID: https://orcid.org/0000-0002-3298-3051)

Ksenofontova Alla G.: Senior Lecturer, Department of Propaedeutics of Internal Diseases with a Course of Radiation Diagnostics, Chuvash State University, Russia, Cheboksary (alla-dok99@yandex.ru; )

Bayukova Svetlana V.: Senior Lecturer, Department of Propaedeutics of Internal Diseases with a Course of Radiation Diagnostics, Chuvash State University, Russia, Cheboksary (bsv58@mail.ru; )

Article link

Vasilyeva L.N., Ksenofontova A.G., Bayukova S.V. Cardiohepatic Syndrome: Innovative Diagnostics by Ultrasound Elastography [Electronic resource] // Acta medica Eurasica. – 2022. – №1. P. 9-18. – URL: https://acta-medica-eurasica.ru/en/single/2022/1/2/. DOI: 10.47026/2413-4864-2022-1-9-18.

Single article

Vasilyeva L.N., Ksenofontova A.G., Bayukova S.V.